SR-02

N/A

Report date: 2026/05/14 20:00:28

Base Information

Drug NameSR-02
Drug Alias NameAllogeneic pancreatic endocrine cell clustersSR-02
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionPancreatic beta cell replacements
TargetsNot applicable
Therapy Area/IndicationsHypoglycemiaDiabetes Mellitus, Type 1Diabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSeraxis Inc
China Registration ClassN/A

Develop Information

Active CompaniesSeraxis Inc
Inactive CompaniesN/A
Active IndicationsHypoglycemiaDiabetes Mellitus, Type 1Diabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A